Loss of cytomegalovirus-specific CD4+T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+T cell counts and recurrent retinitis

Journal of Infectious Diseases

Volumn 183, Issue 8, 2001, Pages 1285-1289

  Komanduri, Krishna V ^a,b   Feinberg, Judith ^e   Hutchins, Robert K ^f,g   Frame, Ronald D ^f   Schmidt, Diane K ^a   Viswanathan, Mohan N ^a   Lalezari, Jacob P ^d   McCune, Joseph M ^a,b,c  

^a GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

^b Depts Med Microbiol and Immunol   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Quest Clinical Research   (United States)

^e Departments of Medicine   (United States)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^g CINCINNATI EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ADULT; ARTICLE; CASE REPORT; CELLULAR IMMUNITY; CLONAL ANERGY; CONTROLLED STUDY; CYTOMEGALOVIRUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE COUNT; MALE; MORBIDITY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RELAPSE; RETINITIS; T LYMPHOCYTE SUBPOPULATION; VIRUS INHIBITION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS RETINITIS; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; RECURRENCE; REFERENCE VALUES;

EID: 0035871870     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/319683     Document Type: Article

References (15)

1. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
2. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
3. High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection
4. +T cell frequencies by flow cytometry: Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency
5. +T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuais infected with HIV-1
6. +T cell responses to CMV in HIV-1-infected subjects
7. +cytotoxic T-cell responses during chronic viral infection
8. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy
9. +T-cell repertoire that are not immediately restored by antiviral or immune-based therapies
10. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis
11. Treatment of immune recovery vitritis with local steroids
12. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study
13. Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection
14. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans
15. Direct evidence for thymic function in adult humans